This information was published on 2019-11-28T00:13:25 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2019362 (IR 1484629) |
| (220) |
27 Jun 2019
|
| (511) (510) |
Class 5
Cellular function activating agents for medical purposes; therapeutic pharmaceutical for the treatment of wounds, skin conditions, orthopaedic conditions including sarcopenia, osteoarthritis and tendinopathy, degenerative eye disease including age related macular degeneration, age related conditions, neurodegenerative disease, depression, bleeding, trauma, stroke, heart disease |
| (540) | CYTARIS |
| (550) | Word |
| (730) |
EXOPHARM LIMITED
ACN/ABN 163765991 |
| (750) |
Herbert Smith Freehills
|
Find out more about publications on the About page.